South and Central America Dialysis Concentrates and Solutions Market Outlook (2021-2031)

The South and Central America dialysis concentrates and solutions market size is expected to reach US$ 205.8 million by 2031 from US$ 148.8 million in 2024. The market is estimated to record a CAGR of 5.4% from 2025 to 2031.

Executive Summary and South and Central America Dialysis Concentrates and Solutions Market Analysis:

The South and Central America dialysis concentrates and solutions market is experiencing strong growth, driven by rising dialysis sessions, increasing customization of treatment compositions, and government support. The region represents a developing market with significant growth potential, fueled by the growing burden of chronic diseases and improvements in healthcare infrastructure. Brazil and Mexico are the largest and most critical markets, based on patient volume and the scale of in-center hemodialysis services. Investment in dialysis care is increasing, with focused efforts to expand access and improve service delivery. The expanding patient population and sustained demand for dialysis consumables position South and Central America as an attractive opportunity for both international and local providers.

South and Central America Dialysis Concentrates and Solutions Market Segmentation Analysis

Key segments that contributed to the derivation of the dialysis concentrates and solutions market analysis are product, application, and end user.

• By product, the dialysis concentrates and solutions market is segmented into acid concentrates, bicarbonate concentrates, powdered concentrates, dialysate, and electrolyte solutions. Acid concentrates dominated the market in 2024, driven by their critical role and high-volume utilization as a core component in hemodialysis, which is the predominant treatment modality across South and Central America.
• In terms of application, the market is segmented into hemodialysis and peritoneal dialysis. Hemodialysis accounted for the largest share in 2024, driven by its long-standing position as the primary treatment for end-stage renal disease (ESRD). This dominance is supported by a substantial patient base and well-established, publicly funded clinical infrastructure across the region.
• By end user, the market is segmented into in-center dialysis settings and home care settings. In-center dialysis dominated the market in 2024, driven by the high prevalence of advanced-stage patients with comorbidities requiring continuous medical supervision. Limited infrastructure and inadequate patient training for home-based care in many parts of the region further reinforce this segment’s leadership.

South and Central America Dialysis Concentrates and Solutions Market Outlook

The South and Central America dialysis concentrates and solutions market is segmented into Brazil, Argentina, Peru, Chile, and Colombia. The dialysis concentrates and solutions market in South and Central America is set for a notable shift toward patient-centric, decentralized care models. While in-center hemodialysis will remain the dominant modality, there is growing emphasis on home-based therapies, particularly peritoneal dialysis (PD). This trend is driven by the need to improve quality of life and reduce healthcare system costs. Governments and providers are actively promoting PD, which is expected to boost demand for related solutions and consumables. The market will also benefit from the increasing adoption of telehealth and remote monitoring technologies. These innovations enable patients in remote or underserved areas to receive professional supervision and ongoing support from home. Future growth will depend on integrating advanced technologies and care models while addressing the critical need for improved access and affordability.

South and Central America Dialysis Concentrates and Solutions Market Country Insights

Based on country, the South and Central America dialysis concentrates and solutions market is segmented into Brazil, Argentina, Peru, Chile, and Colombia. Brazil held the largest share in 2024.

The South and Central America dialysis concentrates and solutions market is highly diverse, with each country presenting unique opportunities. Brazil is the region’s largest and most developed economy, making it a key market for dialysis products and services. The country has a well-established healthcare system with a significant number of patients undergoing in-center hemodialysis. There is a growing trend toward home-based dialysis, driving demand for portable and easy-to-use equipment. Mexico is another major market, with high patient volumes, particularly in peritoneal dialysis. The healthcare system is focused on managing the high prevalence of diabetes and hypertension, which is increasing demand for dialysis solutions. Argentina maintains a strong in-center dialysis tradition but is open to adopting new technologies. Colombia is experiencing steady growth, supported by initiatives to improve care accessibility and promote home-based dialysis as a more efficient alternative.

South and Central America Dialysis Concentrates and Solutions Market Company Profiles

Fresenius Medical Care AG & Co KGaA; Baxter International Inc.; B. Braun SE; Nipro Corp; Medtronic Plc; Nikkiso Co., Ltd; Teleflex Inc; Asahi Kasei Medical Co., Ltd.; Terumo Corp; and DaVita Inc. are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.

South and Central America Dialysis Concentrates and Solutions Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

• Primary Research

Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:

• Refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

South and Central America Dialysis Concentrates and Solutions Key Sources Referred:

• World Health Organization (WHO)
• United States Renal Data System (USRDS)
• The World Bank Group
• Worldometer
• The Lancet
• International Trade Administration